Navin Fluorine International / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-05-15Back to NAVINFLUORINEINTERNATION

Revenue

₹938 Cr

verified against source

Revenue YoY

34%

reported change

EBITDA

₹321 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY26: 213 · Positive source sentiment · 2026-05-15Q4 FY26213213
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Navin Fluorine delivered a strong Q4 FY26 with consolidated revenue of ₹938 crore (+34% YoY) and EBITDA of ₹321 crore (+80% YoY), driven by broad-based growth across HPP (+20%), specialty chemicals (+39%), and CDMO (+61%). EBITDA margin expanded to 34.2% (+992bps YoY), aided by operating leverage, favorable mix, and pricing actions. PAT surged 124% YoY to ₹213 crore. Management highlighted six consecutive quarters of growth, with new capacities (HF plant, R32 expansion, KOS project) transitioning from investment to revenue generation. Guidance for FY27 includes high double-digit revenue growth, EBITDA margin around 30% (±1-2%), and net working capital days improving to 75-80. Key risk: sustained raw material inflation and geopolitical disruptions could pressure margins if pass-through lags.

Colored figures show movement against the previous available record.

Guidance to track

  • Management expects to maintain EBITDA margin at approximately 30% for the full year, plus or minus 1-2%, based on current business circumstances.
  • Additional HFC capacity equivalent to 15,000 MTPA of R32 is expected to be commissioned in Q3 FY27.
  • The KOS project is on track and expected to be completed by end June or early July, transitioning from investment to revenue generation.
  • Management has visibility of up to 80% capacity utilization for specialty chemicals in FY27, supported by order book and pipeline.

Risks flagged

  • Rising raw material costs due to geopolitical tensions may not be fully passed on immediately, potentially compressing margins in the short term.
  • Middle East volatility could disrupt raw material availability, logistics, and energy prices, though management has not seen material impact yet.
  • The Nectar project is expected to reach only 75-80% utilization by end of FY28, slower than initially anticipated, due to qualification delays.
  • If oil prices remain elevated at $150+, global demand could weaken, affecting volumes across segments, though management is not currently planning for this scenario.

Key quotes

  • The growth in this fiscal is supported by contribution across the business verticles led by structural demand drivers and constructive pricing environment.
  • Our near-term priorities are efficient execution of announced capex and improving return ratios while scaling growth.
  • We are closely monitoring and navigating the developments with agility particularly given implications on energy prices, logistics and supply chain disruptions.

Research modules

Go one layer deeper.